This review assesses the evidence for the efficacy of therapies used in the management of
osteoarthritis in dogs on the basis of papers published in peerreviewed journals in English …

OBJECTIVES: To develop recommendations about identifying the causative organism,
obtaining imaging studies, and selecting pharmacological and non-pharmacological …

OBJECTIVE. The introduction of anti–tumor necrosis factor α agents has opened new
prospects in therapeutic management of patients with early rheumatoid arthritis, thereby …

Background Various observations have suggested that the course of COVID-19 might be
less favourable in patients with inflammatory rheumatic and musculoskeletal diseases …

Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-
modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis …

Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD)(hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …

Objective To assess the efficacy and safety of percutaneous vertebroplasty in osteoporotic
vertebral compression fractures responsible for severe and persistent pain. Methods Sixteen …

Objectives There is a need for effective and safe treatment during pregnancy in women with
chronic inflammatory diseases. This study evaluated placental transfer of certolizumab pegol …

Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …

Objective The risk of severe infection is a crucial factor in the assessment of the short‐term
risk: benefit ratio of biologic drugs in rheumatoid arthritis (RA). There is no increase in …